Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HSD17B13 | Q7Z5P4 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16830719 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAKMT2ARECQLGAA | |
| SCHEMBL16846315 | 0.86 | ALDH1A1 (0.47) | ALDH1A1LMNAKMT2ARECQLGAA | |
| Hydrochloric Acid SCHEMBL16830724 | 0.84 | ALDH1A1 (0.46) | ALDH1A1LMNAKMT2ARECQLGAA | |
| Hydrochloric Acid SCHEMBL16830727 | 0.84 | ALDH1A1 (0.46) | ALDH1A1LMNAKMT2ARECQLGAA | |
| SCHEMBL9839056 | 0.82 | ALDH1A1 (0.44) | ALDH1A1LMNAKMT2ARECQLGAA | |
| SCHEMBL9839051 | 0.82 | ALDH1A1 (0.44) | ALDH1A1LMNAKMT2ARECQLGAA | |
| SCHEMBL15224417 | 0.80 | ALDH1A1 (0.40) | ALDH1A1LMNAKMT2ARECQLGAA | |
| SCHEMBL15224418 | 0.80 | ALDH1A1 (0.40) | ALDH1A1LMNAKMT2ARECQLGAA | |
| SCHEMBL16830730 | 0.78 | ALDH1A1 (0.54) | ALDH1A1LMNAKMT2ARECQLGAA | |
| SCHEMBL16846317 | 0.78 | ALDH1A1 (0.51) | ALDH1A1LMNAKMT2ARECQLGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160326153-A1 | N-SUBSTITUTED IMINO HETEROCYCLIC COMPOUNDS | BASF SE (DE) | 2016-11-10 | — | — | US | disclosed |
| EP-3083581-A1 | N-SUBSTITUTED IMINO HETEROCYCLIC COMPOUNDS | BASF SE (DE) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015091649-A1 | N-SUBSTITUTED IMINO HETEROCYCLIC COMPOUNDS | BASF SE (DE) | 2015-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160326153-A1 | N-SUBSTITUTED IMINO HETEROCYCLIC COMPOUNDS | CBR3, C5, PRDX2 | ALDH1A1 4406/4885LMNA 1293/4885KMT2A 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.